MarginView3D: Extending Novel 3D Surgical Pathology Reporting for Use in Invasive pT4 Thyroid Cancer and Other Surgical Oncologic Procedures
Authors' conclusion
We have utilized our novel approach extensively in head and neck cancer. Here, we highlight it as a tool for the management of invasive pT4 thyroid cancer. As a brief summary of new and innovative research, this study introduces MV3DTM as a novel and scalable approach to intraoperative margin assessment and documentation in advanced thyroid cancer, with the potential to inform future practice in surgical oncology.
Study context
- Population
- Invasive pT4 thyroid cancer cases (four tracheal resections, one sternal mass resection)
- Participants
- 5 case series
- Outcome
- Use of MV3D for intraoperative margin assessment and documentation
Main finding
As reported in the abstract
- MarginView3DTM (MV3D) guided intraoperative margin assessment, communication and pathologic documentation in four tracheal resections and one sternal mass resection
- Final surgical pathology report generated for each case, integrating 3D scans, annotated radiographs and audiovisual summaries
- Case 5: real-time surgeon–pathologist communication guided supplemental margins; R0 resection achieved
Observational data: associations, not effects.
Original publication
MarginView3D: Extending Novel 3D Surgical Pathology Reporting for Use in Invasive pT4 Thyroid Cancer and Other Surgical Oncologic Procedures. Thyroid. Published 9 March 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →